by Corina Milic | Aug 12, 2015
The 2014 Annual Report highlights CHAI’s programmatic work around the world, thanks to our many dedicated partners and supporters. Download...
by Corina Milic | Aug 11, 2015
Treating severe malaria with injectable artesunate instead of quinine can substantially reduce mortality. To increase uptake and improve health outcomes, CHAI supported ministries of health in six high-burden countries to overcome barriers to adoption. Learn more...
by Corina Milic | Aug 11, 2015
Access to better tolerated, more convenient regimens for HIV treatment promotes adherence and leads to better patient outcomes. CHAI is working to ensure affordable pricing and to address demand-side barriers to access. Increased uptake of optimal second-line regimens...
by Corina Milic | Aug 11, 2015
CHAI and partners achieved a price reduction agreement for contraceptive implants that increased total implant distribution by 56 percent from 2012 to 2013 and will result in procurement savings of more than US$300 million over six years. Learn more about this...
by Corina Milic | Aug 11, 2015
Achieving universal access to HIV treatment requires using the resources available as efficiently as possible. To this end, CHAI supports 10 countries to conduct annual resource mapping. In Malawi, results have informed the allocation of US$300 million to high-impact...
by Corina Milic | Jul 28, 2015
Viral hepatitis is a major public health problem throughout the world, killing more people every year than HIV.(i) Hepatitis C is a viral disease transmitted through infected bodily fluids and attacks the liver, slowly scarring the organ until the person acquires...
by Corina Milic | Jul 19, 2015
CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and...
by Corina Milic | Jul 16, 2015
CHAI’s Research and Development (R&D) Team works from a unique angle to support CHAI’s ambitions to improve patient outcomes in low- and middle-income countries. In particular, the team works to: 1. Identify, develop, validate, and transfer for manufacture and...
by Corina Milic | May 26, 2015
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV London, May 26, 2015 – ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access...
by Corina Milic | Apr 9, 2015
New agreement will help save mothers’ lives in low-income countries April 8, 2015 An agreement announced today will reduce the achievable cost per use of the non-pneumatic anti-shock garment (NASG) by over 75 percent and expand access to this innovative new...
